Unlock stock picks and a broker-level newsfeed that powers Wall Street.

IOB - Delayed Quote EUR

DSM-Firmenich AG (0AC9.IL)

92.68
-0.64
(-0.69%)
At close: April 25 at 5:34:11 PM GMT+1

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Dimitri de Vreeze CEO, COO & Member of the Managing Board 1.72M -- 1967
Mr. Ralf Schmeitz CFO & Member of Managing Board -- -- 1973
Mr. Dave Huizing VP of Investor Relations -- -- --
Ms. Lieke de Jong-Tops Sr. Communications Mang. -- -- --
Ms. Cristina Monteiro Exec. VP of People & Organization -- -- --
Mr. Luca Rosetto Sr. VP of Operations - Nutritional Products -- -- 1963
Mr. Philip Eykerman Pres of Food Specialties and Corp. Mergers & Acquisitions -- -- 1969
Ms. Patricia Malarkey Chief Innovation Officer -- -- 1965
Mr. Hugh C. Welsh Gen. Counsel, Sec. & Pres of DSM North America -- -- 1966
Mr. Atul Thakrar Pres of Bio-Based Products & Services Unit -- -- --

DSM-Firmenich AG

Wurmisweg 576
Kaiseraugst, 4303
Switzerland
https://www.dsm-firmenich.com
Full Time Employees: 
29,306

Description

DSM-Firmenich AG, a science-based company, engages in beauty, health, and nutrition businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Perfumery & Beauty; Animal Nutrition & Health (ANH); Health, Nutrition & Care (HNC); and Food & Beverage segments. The Perfumery & Beauty offers perfumery and aroma ingredients. The Animal Nutrition & Health segment offers essential products, including vitamins, premixes, and carotenoids; performance solutions, such as enzymes, microbes, and eubiotics; precision services comprising support with data analysis to measure animal health and environmental footprint on farm level and feed safety; and methane reducing feed additive for ruminants. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, personal care and aroma, and biomedical materials markets. It offers vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics and prebiotics, active pharmaceutical ingredients, and sunscreen filters, as well as a range of biomedical solutions; premix, market-ready solutions, and personalized nutrition solutions; and regulatory affairs and formulation expertise, and customized solutions. The Food & Beverage segment provides ingredients and solutions for use in a range of food products, such as dairy; bakery, cereals, and bars; savory food; beverages and brewing; confectionery and fruit; plant-based meat and fish alternatives; and petfood. The company was founded in 1902 and is headquartered in Kaiseraugst, Switzerland.

Corporate Governance

DSM-Firmenich AG’s ISS Governance QualityScore as of October 1, 2023 is 1. The pillar scores are Audit: 1; Board: 1; Shareholder Rights: 1; Compensation: 1.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

February 13, 2025 at 6:00 AM UTC

DSM-Firmenich AG Earnings Date

Recent Events

July 3, 2023 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers